Clinical Trial Update: The Safety and Tolerability Study With ER2001 Intravenous Injection Repetitive Treatment in Adults With Early Manifest Huntington's Disease. [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update on the safety and tolerability study of ER2001 intravenous injections in adults with early manifest Huntington's disease; the EARLY_Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• ER2001

Snippet

Sponsor: ExoRNA Bioscience | Conditions: Huntington Disease | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING